205596-46-9

Upstream product

• 205596-42-5 N-(1,2-Diphenyl-ethyl)-N-(2-phenylsulfanyl-ethyl)-formamide 
• 205596-36-7 (1,2-Diphenyl-ethyl)-(2-phenylsulfanyl-ethyl)-amine 
• 2014-75-7 2-(phenylthio)ethanamine 
• 451-40-1 phenyl benzyl ketone 

Downstream Products

• 205596-56-1 1-Benzyl-4-phenylsulfanyl-3,4-dihydro-1H-isoquinoline-2-carbaldehyde 
• 138967-33-6 1-phenylmethy-3,4-dihydro-1H-isoquinoline-2-carboxaldehyde 
• 19716-56-4 1-benzyl-1,2,3,4-tetrahydroisoquinoline 
• 10225-29-3 1-benzyl-2-methyl-1,2,3,4-tetrahydroisoquinoline 

Relevant academic research and scientific papers

A highly efficient synthesis of 1-methyl-, 1-benzyl-, and 1-phenyl-1,2,3,4-tetrahydroisoquinolines by a modified pummerer reaction

(±)-1-Methyl- (13b), (±)-1-benzyl- (13c), and (±)-1-phenyl- (13d)-1,2,3,4-tetrahydroisoquinolines, which are supposed to participate in the pathogenesis of Parkinson's disease, were prepared by using a modified Pummerer reaction as a key step in excellent overall yields from the commercially available ketones (4b-c).